Unilateral intravitreal dexamethasone implant for the treatment of cystoid macular edema in intermediate uveitis

ABSTRACT This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis. Bearing in mind the adverse effects of the prolonged use of systemic corticosteroids, the objective here was to provide a less damaging form of intervention, and also to demonstrate the safety of the dexamethasone implant for patients who fail to respond to conventional treatment. In the present case, there was bilateral improvement in retinal anatomy and function with use of the unilateral intravitreal dexamethasone implant (Ozurdex®).

摘要 本报告旨在探讨单侧玻璃体内地塞米松植入剂（Ozurdex®）治疗复发性中间型葡萄膜炎（recurrent intermediate uveitis）患者囊样黄斑水肿（cystoid macular edema）的疗效。鉴于长期全身使用糖皮质激素会产生不良反应，本研究旨在提供一种损伤更小的干预手段，同时验证地塞米松植入剂对常规治疗应答不佳患者的安全性。本病例中，采用单侧玻璃体内地塞米松植入剂（Ozurdex®）治疗后，患者的视网膜解剖结构与功能均得到双侧改善。